SCHEMBL573855

SCHEMBL573855

COC(=O)c1cc([N+](=O)[O-])c(Cl)c(S(=O)(=O)N(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VCAM1 P19320 2/20 0.52
▸ ALDH1A1 P00352 6/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ POLB P06746 3/20 0.43
▸ MAPT P10636 4/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LMNA P02545 4/20 0.41
▸ PDE2A O00408 1/20 0.41
▸ PDE5A O76074 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL573520 0.85 HCAR3 (0.47) VCAM1ALDH1A1MEN1KMT2ANPC1
SCHEMBL7822590 0.85 VCAM1 (0.67) VCAM1ALDH1A1POLBMAPTKDM4E
SCHEMBL11389391 0.85 VCAM1 (0.56) VCAM1ALDH1A1MEN1KMT2APOLB
SCHEMBL573521 0.84 VCAM1 (0.54) VCAM1ALDH1A1MEN1KMT2APOLB
SCHEMBL573293 0.82 VCAM1 (0.47) VCAM1ALDH1A1POLBMAPTKDM4E
SCHEMBL573292 0.82 VCAM1 (0.47) VCAM1ALDH1A1POLBMAPTKDM4E
SCHEMBL28610250 0.82 VCAM1 (0.47) VCAM1ALDH1A1MEN1KMT2APOLB
SCHEMBL645817 0.82 VCAM1 (0.55) VCAM1ALDH1A1MEN1KMT2APOLB
SCHEMBL11388406 0.79 FBP1 (0.50) VCAM1ALDH1A1MEN1KMT2APOLB
SCHEMBL573529 0.78 VCAM1 (0.51) VCAM1ALDH1A1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback